IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER

Fallopian Tube Cancer

Millennium Pharmaceuticals, Inc.monoclonal_antibodyPhase 2Dormant

CCC

51/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 42/ 100
Competitive Position: 65/ 100

Competitive context

116 Active assets in the Fallopian Tube Cancer cohort.

Asset / Sponsor	Phase	Rating
Mirvetuximab Soravtansine AbbVie	Phase 3	BB
Inno-206 Sichuan Baili Pharmaceutical Co., Ltd.	Phase 3	BB
Carboplatin Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Phase 3	BB
Irinotecan Tianjin Medical University Cancer Institute and Hospital	Phase 3	BB
(+)-VINCRISTINE AbbVie	Phase 3	BB

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:

Recurrent Adult Burkitt LymphomaDormant

BBB

Indicative ·

78 / 100

View asset →

Recurrent Adult Diffuse Small Cleaved Cell LymphomaDormant

BBB

Indicative ·

76 / 100

View asset →

lymphoblastic lymphomaDormant

BBB